Author
Listed:
- In-Hyun Park
(Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School)
- Rui Zhao
(Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School)
- Jason A. West
(Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School)
- Akiko Yabuuchi
(Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School)
- Hongguang Huo
(Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School)
- Tan A. Ince
(Brigham and Women’s Hospital, and)
- Paul H. Lerou
(Brigham & Women’s Hospital and Children’s Hospital Boston, Boston, Massachusetts 02115, USA)
- M. William Lensch
(Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School)
- George Q. Daley
(Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School)
Abstract
Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture.
Suggested Citation
In-Hyun Park & Rui Zhao & Jason A. West & Akiko Yabuuchi & Hongguang Huo & Tan A. Ince & Paul H. Lerou & M. William Lensch & George Q. Daley, 2008.
"Reprogramming of human somatic cells to pluripotency with defined factors,"
Nature, Nature, vol. 451(7175), pages 141-146, January.
Handle:
RePEc:nat:nature:v:451:y:2008:i:7175:d:10.1038_nature06534
DOI: 10.1038/nature06534
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:451:y:2008:i:7175:d:10.1038_nature06534. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.